The Children's Health System of Texas, doing business as the Children's Medical Center of Dallas, has been awarded a $3,000,000 Project Grant under the Congressional Directives program (CFDA 93.493) by the U.S. Department of Health and Human Services. This 3-year award, effective from September 30, 2023 to September 29, 2026, will support the construction and renovation of healthcare facilities operated by the Children's Medical Center of Dallas, a non-profit hospital. The Congressional...
This $3,000,000 Project Grant award from the Department of Health and Human Services (HHS) under the Congressional Directives program (CFDA 93.493) will fund construction and renovation activities at the University of Texas Health Science Center at San Antonio (UTHSCSA). The award, made on September 30, 2023, supports a 3-year project to be completed by September 29, 2026. As a leading academic medical center and research institution, UTHSCSA will leverage this funding to expand its facilities...
The Children's Health System of Texas, doing business as Children's Medical Center of Dallas, has been awarded a $4,000,000 Project Grant under the U.S. Department of Health and Human Services' (HHS) Congressional Directives program (CFDA 93.493). The grant, awarded on September 30, 2023, will support construction and renovation projects at the organization's healthcare facilities in Dallas, Texas. The funding is intended to address specific local and regional needs as directed by Congress, with...
The University of Texas Southwestern Medical Center (UT Southwestern) was awarded a $1,083,136 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will support research from August 15, 2023 through August 14, 2026 to leverage SCARB1 overexpression for the treatment of clear cell renal cell carcinoma (CCRCC) using low-density lipoprotein nanocarriers. UT Southwestern has extensive experience delivering...
The University of Texas Southwestern Medical Center (UT Southwestern) was awarded a $713,689 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The three-year grant, effective September 1, 2023, will support UT Southwestern's research to leverage biophysicochemical motifs in T-cell receptor antigen binding regions and antigen co-occurrence to predict response to immune checkpoint inhibitors. The grant provides funding for basic...
The University of Texas Southwestern Medical Center (UT Southwestern) was awarded a $536,559 Cooperative Agreement grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. This award supports a clinical trial site application for the Kidney Cancer Research Consortium, with a period of performance from September 15, 2024 to September 14, 2026. UT Southwestern, a prominent academic medical center in Dallas, Texas, has extensive...
This $8,000,000 Congressionally Directed Spending for Construction Projects grant was awarded by the U.S. Department of Health and Human Services (CFDA 93.493 - Congressional Directives) to Texas Tech University Health Sciences Center (TTUHSC) on September 30, 2023. The grant will support the construction and renovation of healthcare facilities, as well as the purchase of necessary equipment. As a state-controlled institution of higher learning, TTUHSC will leverage its expertise in biomedical...
This federal Project Grant award in the amount of $617,537 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award, with a performance period from September 1, 2024 to August 31, 2027, supports research conducted by The University of Texas Southwestern Medical Center (UT Southwestern) to examine heterogeneity in response to disease-modifying therapy for multiple sclerosis. As a prominent academic medical center, UT...
The University of Texas Southwestern Medical Center (UT Southwestern) has been awarded a Project Grant for $1,180,962.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on June 30, 2024, will support a research project titled "TUMOR SURFACE BIOMARKER-INDEPENDENT TARGETING OF KIDNEY CANCER TO IMPROVE IMMUNOTHERAPY" over a performance period ending on June 29, 2027. The grant funding will enable UT...
The University of Texas Southwestern Medical Center (UT Southwestern) was awarded a $319,798 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) on April 15, 2024. The grant supports UT Southwestern's research to dissect unconventional mechanisms of action and resistance to rapalogs, a class of drugs, in renal cell carcinoma. The research aims to make significant advances in military medicine by improving...